1
Syntheses
93%. trans-2c: H NMR (300 MHz, CDCl3): d 7.63–7.58 (dd,
2 H, Ar–H), 7.26–7.21 (m, 3 H, Ar–H), 7.12–7.10 (d, 2 H, Ar–H),
6.05 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 2.52 (s, 6 H,
Dibromo-(cyclohexylisocyanide)-(1,3-diisopropylbenzimidazo-
lin-2-ylidene)palladium(II) (2a). Complex 1 (94 mg, 0.10 mmol)
and cyclohexyl isocyanide (25 ml, 0.2 mmol) were dissolved in
dry THF (10 ml) and stirred at ambient temperature for 5
h under nitrogen. The volatiles were removed under reduced
pressure. The residue was washed with hexane (15 ml ¥ 3) and
dried in vacuo. Crystallization by diffusion of pentane into a
concentrated CHCl3 solution afforded the product as yellow
crystals. Total yield: 98 mg, 0.17 mmol, 85%. trans-2a: 1H NMR
(300 MHz, CDCl3): d 7.57–7.54 (dd, 2 H, Ar–H), 7.22–7.19 (dd,
3
1
CH3), 1.77 (d, J(H,H) = 7.1 Hz, 12 H, NCH(CH3)2). 13C{ H}
NMR (75.47 MHz, CDCl3): 168.3 (s, Ccarbene), 136.2, 133.3, 130.0,
128.0, 122.6, 112.9 (s, Ar–C), 54.4 (s, NCH(CH3)2), 20.8 (s,
∫
NCH(CH3)2), 18.7 (s, CH3). The C N and Ar-CN signals could
not be detected. cis-2c: 1H NMR (300 MHz, CDCl3): d 7.68–7.65
(dd, 2 H, Ar–H), 7.34–7.31 (dd, 2 H, Ar–H), 7.25–7.21 (t, 1 H,
3
Ar–H), 7.08–7.05 (d, 2 H, Ar–H), 6.05 (m, J(H,H) = 7.1 Hz,
2 H, NCH(CH3)2), 2.28 (s, 6 H, CH3), 1.79 (d, 3J(H,H) = 7.1 Hz,
6 H, NCH(CH3)2), 1.72 (d, 3J(H,H) = 7.1 Hz, 6 H, NCH(CH3)2).
2 H, Ar–H), 5.98 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 3.88
13C{ H} NMR (75.47 MHz, CDCl3): 163.9 (s, Ccarbene), 135.7,
1
3
∫
(m, 1 H, C NCH), 1.89–1.77 (m, 6 H, CH2), 1.72 (d, J(H,H) =
133.3, 130.5, 128.3, 123.4, 113.1 (s, Ar–C), 54.4 (s, NCH(CH3)2),
7.1 Hz, 12 H, NCH(CH3)2), 1.43–1.32 (m, 4 H, CH2). 13C{ H}
1
∫
21.1, 20.4 (s, NCH(CH3)2), 18.6 (s, CH3). The C N and Ar-CN
signals could not be detected. trans-2c and cis-2c: IR (KBr pellet)
n = 2194 (s, C N) cm . Anal. Calc. for C22H27N3Br2Pd: C,
44.06; H, 4.54; N, 7.01. Found: C, 44.03; H, 4.40; N, 6.86%. MS
(FAB): m/z = 651 [M - Br + C9H9N]+.
Tetrabromo-bis(1,3-diisopropylbenzimidazolin-2-ylidene)-l-(hy-
drazine)dipalladium(II) (6). Complex 2c (90 mg, 0.15 mmol) and
hydrazine monohydrate (3.6 ml, 0.075 mmol) were dissolved in
CH2Cl2 (5 ml) and stirred at ambient temperature overnight. The
resulting mixture was filtered over Celite and the solvent was
removed under reduced pressure. Upon adding CHCl3 (2 ml) to the
residue, yellow precipitates were formed and collected by filtration.
Reducing the solvent of the filtrate to 1 ml followed by prolonged
stirring (3 h) afforded a second crop of a yellow precipitate. The
yellow precipitate was combined and dried in vacuo to give the
product (33 mg, 0.034 mmol, 45%). 1H NMR (500 MHz, CD2Cl2):
d 7.61–7.59 (m, 4 H, Ar–H), 7.25–7.23 (m, 4 H, Ar–H), 6.21
NMR (75.47 MHz, CDCl3): 168.5 (s, Ccarbene), 133.4 (s, Ar–C),
∫
∫
129.7 (br, C N), 122.5, 112.9 (s, Ar–C), 55.5 (s, C NC), 54.4 (s,
NCH(CH3)2), 31.9, 24.9, 22.5 (s, CH2), 20.8 (s, NCH(CH3)2). cis-
-1
∫
˜
1
2a: H NMR (300 MHz, CDCl3): d 7.64–7.61 (dd, 2 H, Ar–H),
3
7.31–7.28 (dd, 2 H, Ar–H), 5.92 (m, J(H,H) = 7.1 Hz, 2 H,
∫
NCH(CH3)2), 3.80 (m, 1 H, C NCH), 1.89–1.77 (m, 6 H, CH2),
1.73 (d, 3J(H,H) = 7.1 Hz, 6 H, NCH(CH3)2), 1.67 (d, 3J(H,H) =
7.1 Hz, 6 H, NCH(CH3)2), 1.43–1.32 (m, 4 H, CH2). 13C{ H}
1
NMR (75.47 MHz, CDCl3): 164.6 (s, Ccarbene), 133.5 (s, Ar–C),
∫
123.3, 113.1 (s, Ar–C), 54.5 (s, NCH(CH3)2), 52.4 (s, C NC), 32.0,
24.5, 22.6 (s, CH2), 21.2, 20.5 (s, NCH(CH3)2). The C N signal
∫
˜
could not be detected. trans-2a and cis-2a: IR (KBr pellet) n =
-1
∫
2234 (s, C N) cm . Anal. Calc. for C20H29N3Br2Pd: C, 41.58; H,
5.06; N, 7.27. Found: C, 41.94; H,5.07; N, 7.23%. MS (FAB):
m/z = 498 [M - Br]+.
Dibromo-(n-butylisocyanide)-(1,3-diisopropylbenzimidazolin-2-
ylidene)palladium(II) (2b). 2b was prepared in analogy to 2a from
complex 1 (94 mg, 0.10 mmol) and n-butyl isocyanide (21 ml,
3
(m, J(H,H) = 6.9 Hz, 4 H, NCH(CH3)2), 4.72 (s, 4 H, NH2),
1.73 (d, J(H,H) = 6.9 Hz, 24 H, NCH(CH3)2). 13C{ H} NMR
(125.76 MHz, CD2Cl2): 159.9 (s, Ccarbene), 133.7, 122.8, 113.0 (s,
Ar–C), 54.9 (s, NCH(CH3)2), 20.7 (s, NCH(CH3)2). IR (KBr
˜
3
1
1
0.2 mmol). Total yield: 105 mg, 0.19 mmol, 95%. trans-2b: H
NMR (300 MHz, CDCl3): d 7.57–7.54 (dd, 2 H, Ar–H), 7.22–7.19
(dd, 2 H, Ar–H), 5.97 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2),
pellet)
n
=
3233, 3143 (m, NH) cm-1. Anal. Calc. for
∫
3.64 (t, 2 H, C NCH2), 1.74–1.65 (m, 2 H, CH2), 1.72 (d,
C26H40N6Br4Pd2: C, 32.22; H, 4.16; N, 8.67. Found: C, 31.46; H,
4.03; N, 8.24% (better results could not be obtained although the
1H and 13C NMR spectra do not show any impurities). MS (ESI):
m/z = 889 [M - Br]+.
cis-(1,3-Diisopropylbenzimidazolin-2-ylidene)-(2,6-dimethyl-phe-
nylisocyanide)-bis(trifluoroacetato)palladium(II) (7). A mixture
of complex 2c (120 mg, 0.20 mmol) and AgO2CCF3 (93 mg,
0.42 mmol) was suspended in acetonitrile (10 ml) and stirred
at ambient temperature overnight shielded from light. The
reaction mixture was filtered over Celite and the solvent of the
filtrate was removed under reduced pressure. To the residue was
added CHCl3 (15 ml) and the resulting mixture was filtered over
Celite. Removing the solvent of the filtrate in vacuo afforded the
3J(H,H) = 7.1 Hz, 12 H, NCH(CH3)2), 1.55–1.45 (m, 2 H, CH2),
0.95 (t, 3 H, CH3). 13C{ H} NMR (75.47 MHz, CDCl3): 168.3 (s,
1
Ccarbene), 133.4, 122.5, 113.0 (s, Ar–C), 54.4 (s, NCH(CH3)2), 43.9
∫
(br, C NC), 30.5 (s, CH2), 20.8 (s, NCH(CH3)2), 19.5 (s, CH2), 13.2
1
∫
(s, CH3). The C N signal could not be detected. cis-2b: H NMR
(300 MHz, CDCl3): d 7.64–7.61 (dd, 2 H, Ar–H), 7.31–7.28 (dd,
2 H, Ar–H), 5.91 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 3.59
3
∫
(t, 2 H, C NCH2), 1.74–1.65 (m, 2 H, CH2), 1.73 (d, J(H,H) =
7.1 Hz, 6 H, NCH(CH3)2), 1.67 (d, 3J(H,H) = 7.1 Hz, 6 H,
NCH(CH3)2), 1.32–1.23 (m, 2 H, CH2), 0.81 (t, 3 H, CH3). 13C{ H}
1
NMR (75.47 MHz, CDCl3): 164.4 (s, Ccarbene), 133.5, 123.3, 113.1 (s,
∫
Ar–C), 54.6 (s, NCH(CH3)2), 44.7 (br, C NC), 30.4 (s, CH2), 21.2,
20.5 (s, NCH(CH3)2), 19.4 (s, CH2), 13.0 (s, CH3). The C N signal
∫
1
product as white powder (126 mg, 0.19 mmol, 95%). H NMR
˜
could not be detected. trans-2b and cis-2b: IR (KBr pellet) n=
(500 MHz, CDCl3): d 7.69–7.67 (m, 2 H, Ar–H), 7.37–7.35 (m,
2 H, Ar–H), 7.23 (t, 1 H, Ar–H), 7.06 (d, 2 H, Ar–H), 6.14 (m,
3J(H,H) = 6.9 Hz, 2 H, NCH(CH3)2), 2.17 (s, 6 H, CH3), 1.82
-1
∫
2229 (s, C N) cm . Anal. Calc. for C18H27N3Br2Pd: C, 39.19; H,
4.93; N, 7.62. Found: C, 38.98; H, 4.75; N, 7.50%. MS (FAB):
m/z = 472 [M-Br]+, 555 [M - Br + C5NH9]+.
3
3
(d, J(H,H) = 6.9 Hz, 6 H, NCH(CH3)2), 1.75 (d, J(H,H) =
1
Dibromo-(1,3-diisopropylbenzimidazolin-2-ylidene)-(2,6-dimethyl-
phenylisocyanide)palladium(II) (2c). 2c was prepared in analogy
to 2a from complex 1 (281 mg, 0.30 mmol) and 2,6-dimethylphenyl
isocyanide (79 mg, 0.60 mmol). Total yield: 335 mg, 0.56 mmol,
6.9 Hz, 6 H, NCH(CH3)2). 13C{ H} NMR (125.76 MHz, CDCl3):
162.4 (q, 2J(C,F) = 37.6 Hz, O2CCF3), 161.6 (q, 2J(C,F) =
38.5 Hz, O2CCF3), 155.9 (s, Ccarbene), 136.0, 133.2, 131.1, 128.6 (s,
∫
Ar–C), 127.9, 125.1 (br, Ar-CN and C N), 124.0 (s, Ar–C), 116.0
2208 | Dalton Trans., 2009, 2201–2209
This journal is The Royal Society of Chemistry 2009
©